CTLA4 and neoplasm: It has been reported that CTLA-4 siRNA-loaded nanoparticles could increase the number of CD8+ T cells, decrease the ratio of CD4+ FOXP3+ Tregs and effectively inhibited tumor growth in mice with melanoma [20].